OTCMKTS:PURE PURE Bioscience (PURE) Stock Price, News & Analysis $0.08 -0.01 (-8.78%) As of 02:26 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartEarningsHeadlinesSEC FilingsShort InterestBuy This Stock About PURE Bioscience Stock (OTCMKTS:PURE) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get PURE Bioscience alerts:Sign Up Key Stats Today's Range$0.08▼$0.1050-Day Range$0.06▼$0.1152-Week Range$0.05▼$0.21Volume25,010 shsAverage Volume54,861 shsMarket Capitalization$9.19 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview PURE Bioscience, Inc. develops and commercializes antimicrobial products that provide solutions to the health and environmental challenges of pathogen and hygienic control in the United States and internationally. The company manufactures and distributes silver dihydrogen citrate (SDC), a non-toxic antimicrobial agent, which offers residual protection, as well as formulates with other compounds. It offers SDC-based disinfecting and sanitizing products, including PURE Hard Surface, a food contact surface sanitizer and disinfectant; PURE Control, a food contact processing aid for fresh produce and raw poultry; PURE Multi-Purpose and Floor Cleaner Concentrate to clean various resilient surfaces, including floors, glass, and food contact surfaces; and PURE Multi-Purpose Hi-Foam Cleaner Concentrate to clean stainless steel equipment, resilient floors, walls, and painted surfaces. The company also provides Axen30, a hard surface disinfectant; Axenohl, an antimicrobial formulation for use as a raw material ingredient in the manufacturing of consumer and commercial disinfecting and sanitizing products; and SILVÉRION, an antimicrobial formulation that is used against bacteria, viruses, yeasts, and molds. PURE Bioscience, Inc. was incorporated in 1992 and is headquartered in Rancho Cucamonga, California. Read More Receive PURE Stock News and Ratings via Email Sign-up to receive the latest news and ratings for PURE Bioscience and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. PURE Stock News HeadlinesBecton Dickinson Biosciences & Diagnostics Unit to Merge With Waters Corp. in $17.5 Billion DealJuly 15, 2025 | msn.comPURE Bioscience Partners with Bonsai for Direct-to-Customer SalesJune 26, 2025 | finance.yahoo.com“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank accounts nationwide. It will give them unprecedented powers to control your bank account.August 28 at 2:00 AM | Weiss Ratings (Ad)PURE Bioscience Reports Fiscal Third Quarter 2025 Financial ResultsJune 16, 2025 | businesswire.comPURE Bioscience Stock (OTC:PURE), Guidance and ForecastJune 13, 2025 | benzinga.comPURE Bioscience (OTC:PURE) Stock, Insider Trading ActivityJune 12, 2025 | benzinga.comPURE Bioscience innovates dairy, beverage membrane treatmentJune 4, 2025 | investing.comPURE Bioscience Unveils Revolutionary Membrane Treatment Solution for the Dairy and Beverage IndustryJune 2, 2025 | businesswire.comSee More Headlines PURE Stock Analysis - Frequently Asked Questions How have PURE shares performed this year? PURE Bioscience's stock was trading at $0.0638 on January 1st, 2025. Since then, PURE stock has increased by 28.7% and is now trading at $0.0821. How were PURE Bioscience's earnings last quarter? PURE Bioscience (OTCMKTS:PURE) released its quarterly earnings results on Monday, June, 16th. The company reported ($0.01) earnings per share for the quarter. The company had revenue of $0.49 million for the quarter. How do I buy shares of PURE Bioscience? Shares of PURE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of PURE Bioscience own? Based on aggregate information from My MarketBeat watchlists, some other companies that PURE Bioscience investors own include Meta Platforms (META), Hydrofarm Holdings Group (HYFM), Twilio (TWLO), NVIDIA (NVDA), Overstock.com (OSTK), Enphase Energy (ENPH) and Novavax (NVAX). Company Calendar Last Earnings6/16/2025Today8/28/2025Fiscal Year End7/31/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry MED PRODUCTS Sub-IndustryChemicals Current SymbolOTCMKTS:PURE CIK1006028 Webwww.purebio.com Phone(619) 596-8600Fax619-596-8790Employees10Year Founded1992Profitability EPS (Trailing Twelve Months)($0.04) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$3.35 million Net Margins-147.72% Pretax Margin-147.72% Return on EquityN/A Return on Assets-334.78% Debt Debt-to-Equity RatioN/A Current Ratio1.08 Quick Ratio0.94 Sales & Book Value Annual Sales$1.96 million Price / Sales4.69 Cash FlowN/A Price / Cash FlowN/A Book Value($0.03) per share Price / Book-2.74Miscellaneous Outstanding Shares111,890,000Free Float63,171,000Market Cap$9.19 million OptionableNot Optionable Beta0.38 Social Links The 10 Best AI Stocks to Own in 2025Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free Report This page (OTCMKTS:PURE) was last updated on 8/28/2025 by MarketBeat.com Staff From Our PartnersNVIDIA's Worst Nightmare?$2 TRILLION Quantum Gold Rush While everyone fights over expensive AI stocks... McKinsey just revealed the ...The Oxford Club | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredWhat Are Some Strategies to Help Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredTrump’s national nightmare is hereAI is no longer just about chatbots — it’s becoming the backbone of the global economy. While U.S. firms push ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PURE Bioscience Please log in to your account or sign up in order to add this asset to your watchlist. Share PURE Bioscience With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.